Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05118633 · ClinicalTrials.gov registry record · NA
Technology Assisted Treatment for Trichotillomania
A NA study, sponsored by HabitAware.
- Recruiting
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT05118633: Recruiting NA study, sponsored by HabitAware.
NCT05118633 is a NA study that is actively recruiting participants, run by HabitAware. The registered enrollment target is 90 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05118633, a NA study, is actively recruiting participants, sponsored by HabitAware.
- RECRUITING
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
The investigators are testing two digital health interventions for trichotillomania (TTM), via a randomized trial design.
Primary Outcome
Scores on the NIMH Trichotilomania Severity Scale (NIMH-TSS), a clinician-administered assessment of TTM symptom severity, will be compared across conditions at endpoint (week 8), controlling for baseline severity. The NIMH-TSS is a 5-item clinician rated measure of TTM severity ranging from 0-25, with higher scores indicating more severe symptoms.
Interventions
- DEVICE Keen2 bracelet
- DEVICE Reminder bracelet
- BEHAVIORAL Keen2 app
- BEHAVIORAL Health Reminders App
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2026-05-15 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT05118633 shows while recruiting
NCT05118633 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 4 interventions - of which Keen2 bracelet is the first listed.
NCT05118633 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05118633 about?
NCT05118633 is a clinical study titled "Technology Assisted Treatment for Trichotillomania". The investigators are testing two digital health interventions for trichotillomania (TTM), via a randomized trial design.
What is the current status of trial NCT05118633?
This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2026-05-15. Estimated completion is 2026-12-31.
What interventions are being tested in trial NCT05118633?
The interventions under investigation include: Keen2 bracelet (DEVICE), Reminder bracelet (DEVICE), Keen2 app (BEHAVIORAL), Health Reminders App (BEHAVIORAL).
Who is sponsoring clinical trial NCT05118633?
This trial is sponsored by HabitAware, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05118633's enrollment target sits among peer trials
90 941st of 2000 higher than 1,029 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI